My Quote Request
No products added yet
6505-01-123-2288
20 Products
NDC00015-0503-03
CYCLOPHOSPHAMIDE TABLETS,USP
NSN, MFG P/N
6505011232288
NSN
6505-01-123-2288
NDC00015-0503-03
CYCLOPHOSPHAMIDE TABLETS,USP
NSN, MFG P/N
6505011232288
NSN
6505-01-123-2288
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00168-0204-37
LIDOCAINE OINTMENT,USP
NSN, MFG P/N
6505011230034
NSN
6505-01-123-0034
NDC00168-0204-37
LIDOCAINE OINTMENT,USP
NSN, MFG P/N
6505011230034
NSN
6505-01-123-0034
MFG
NYCOMED US INC. DIV FOUGERA/SAVAGE LABS/PHARMADERM USE CAGE CODE 60910 FOR CATALOGING.
Description
ACTIVE INGREDIENT AND STRENGTH: 5.000 LIDOCAINE PERCENTAGE, W/W
PRIMARY CONTAINER CONTENT QUANTITY: 1.250 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
Related Searches:
215
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011230284
NSN
6505-01-123-0284
215
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011230284
NSN
6505-01-123-0284
MFG
FLEET COMPANY INCORPORATED C. B. DBA FLEET
Description
COMPONENT BREAKDOWN WITHIN EACH TEST KIT: 6 1-1/2 OZ.BOTTLE FLAVORED CASTOR OIL EMULSION STIMULANT LAXATIVE 1;5 MG ENTERIC COATED BISACODYL TABLET CONTACT LAXATIVE 4;1-1/4 OZ BOTTLE 10 MG BISACODYL USP LIQUID ENEMA 1;
Related Searches:
FLEET PREP KIT 6
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011230284
NSN
6505-01-123-0284
FLEET PREP KIT 6
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011230284
NSN
6505-01-123-0284
MFG
FLEET COMPANY INCORPORATED C. B. DBA FLEET
Description
COMPONENT BREAKDOWN WITHIN EACH TEST KIT: 6 1-1/2 OZ.BOTTLE FLAVORED CASTOR OIL EMULSION STIMULANT LAXATIVE 1;5 MG ENTERIC COATED BISACODYL TABLET CONTACT LAXATIVE 4;1-1/4 OZ BOTTLE 10 MG BISACODYL USP LIQUID ENEMA 1;
Related Searches:
NDC00132-0215-01
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011230284
NSN
6505-01-123-0284
NDC00132-0215-01
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011230284
NSN
6505-01-123-0284
MFG
FLEET COMPANY INCORPORATED C. B. DBA FLEET
Description
COMPONENT BREAKDOWN WITHIN EACH TEST KIT: 6 1-1/2 OZ.BOTTLE FLAVORED CASTOR OIL EMULSION STIMULANT LAXATIVE 1;5 MG ENTERIC COATED BISACODYL TABLET CONTACT LAXATIVE 4;1-1/4 OZ BOTTLE 10 MG BISACODYL USP LIQUID ENEMA 1;
Related Searches:
NDC00005-3735-57
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011230334
NSN
6505-01-123-0334
NDC00005-3735-57
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011230334
NSN
6505-01-123-0334
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS PSEUDOEPHEDRINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CARAFATE
SUCRALFATE TABLETS
NSN, MFG P/N
6505011230984
NSN
6505-01-123-0984
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS SUCRALFATE ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SUCRALFATE TABLETS 1GM 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CARAFATE TABLETS
SUCRALFATE TABLETS
NSN, MFG P/N
6505011230984
NSN
6505-01-123-0984
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS SUCRALFATE ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SUCRALFATE TABLETS 1GM 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00088-1712-47
SUCRALFATE TABLETS
NSN, MFG P/N
6505011230984
NSN
6505-01-123-0984
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS SUCRALFATE ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SUCRALFATE TABLETS 1GM 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00093-2210-01
SUCRALFATE TABLETS
NSN, MFG P/N
6505011230984
NSN
6505-01-123-0984
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS SUCRALFATE ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SUCRALFATE TABLETS 1GM 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00074-9106-01
DOPAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011231673
NSN
6505-01-123-1673
NDC00074-9106-01
DOPAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011231673
NSN
6505-01-123-1673
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS DOPAMINE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: PIN TOP VIAL
Related Searches:
NDC00054-8749-25
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
NDC00054-8749-25
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS 324MG I.S. 100S
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00677-0675-01
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
NDC00677-0675-01
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
MFG
BAXTER HEALTHCARE CORP BAXTER AIRLIFE/PHARMASEAL DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS 324MG I.S. 100S
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00781-1804-13
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
NDC00781-1804-13
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS 324MG I.S. 100S
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC50419-0101-11
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
NDC50419-0101-11
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS 324MG I.S. 100S
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC51079-0027-20
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
NDC51079-0027-20
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS 324MG I.S. 100S
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC53489-0141-01
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
NDC53489-0141-01
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS 324MG I.S. 100S
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
QUINAGLUTE DURA-TAB
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
QUINAGLUTE DURA-TAB
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505011232287
NSN
6505-01-123-2287
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS 324MG I.S. 100S
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
CYTOXAN
CYCLOPHOSPHAMIDE TABLETS,USP
NSN, MFG P/N
6505011232288
NSN
6505-01-123-2288
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
CYTOXAN TABLETS
CYCLOPHOSPHAMIDE TABLETS,USP
NSN, MFG P/N
6505011232288
NSN
6505-01-123-2288
CYTOXAN TABLETS
CYCLOPHOSPHAMIDE TABLETS,USP
NSN, MFG P/N
6505011232288
NSN
6505-01-123-2288
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 1
